{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:23:16Z","timestamp":1772893396564,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.pupt.2006.03.002","type":"journal-article","created":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T21:11:45Z","timestamp":1149196305000},"page":"273-280","source":"Crossref","is-referenced-by-count":22,"title":["Effects of capsazepine on human small airway responsiveness unravel a novel class of bronchorelaxants"],"prefix":"10.1016","volume":"20","author":[{"given":"Staffan","family":"Skogvall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda F.","family":"Dalence-Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"J\u00f6nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl G.A.","family":"Persson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olov","family":"Sterner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2006.03.002_bib1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/pulp.1995.1028","article-title":"Mechanisms and modulation of capsaicin activity on airway afferent nerves","volume":"8","author":"Fox","year":"1995","journal-title":"Pulm Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1476-5381.1992.tb12781.x","article-title":"Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin","volume":"107","author":"Bevan","year":"1992","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib3","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1021\/jm030560j","article-title":"Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?","volume":"47","author":"Szallasi","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pupt.2006.03.002_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-2999(93)90473-U","article-title":"Inhibitory effects of capsazepine and SR 48968 on citric acid-induced bronchoconstriction in guinea-pigs","volume":"236","author":"Satoh","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib5","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1124\/jpet.102.039727","article-title":"Characterization of the vanilloid receptor 1 antagonist iodo-resiniferatoxin on the afferent and efferent function of vagal sensory C-fibers","volume":"303","author":"Undem","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pupt.2006.03.002_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-2999(03)02114-9","article-title":"Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder","volume":"475","author":"Harrison","year":"2003","journal-title":"Eur J Pharm"},{"key":"10.1016\/j.pupt.2006.03.002_bib7","doi-asserted-by":"crossref","first-page":"L460","DOI":"10.1152\/ajplung.00252.2004","article-title":"Capsazepine, a vanilloid antagonist, abolishes tonic responses induced by 20-HETE on guinea pig airway smooth muscle","volume":"288","author":"Rousseau","year":"2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.pupt.2006.03.002_bib8","series-title":"Drug therapy for asthma. Lung biology in health and disease","first-page":"129","article-title":"In vitro responses to bronchodilator drugs","author":"Persson","year":"1987"},{"key":"10.1016\/j.pupt.2006.03.002_bib9","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1476-5381.1995.tb15926.x","article-title":"Potassium currents in human freshly isolated bronchial smooth muscle cells","volume":"115","author":"Snetkov","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0031-6997(24)01403-0","article-title":"Vanilloid (capsaicin) receptors and mechanisms","volume":"51","author":"Szallasi","year":"1999","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pupt.2006.03.002_bib11","first-page":"1171","article-title":"Mechanics of airway narrowing","volume":"133","author":"Moreno","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.pupt.2006.03.002_bib12","unstructured":"Skogvall S, Bjork H, Berglund PM, Dalence GMF, Sterner O. Method for identifying bronchoconstriction-relaxing substances. US Patent Applied Publications 2005163712 A1, 2005."},{"key":"10.1016\/j.pupt.2006.03.002_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1124\/mol.62.4.947","article-title":"High affinity antagonists of the vanilloid receptor","volume":"62","author":"Wang","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib14","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1021\/jm00039a006","article-title":"The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin","volume":"37","author":"Walpole","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.pupt.2006.03.002_bib15","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00210-001-0522-x","article-title":"Relaxant effect of capsazepine in the isolated rat ileum","volume":"365","author":"Nocerino","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(92)90054-8","article-title":"Capsazepine as a selective antagonist of capsaicin-induced activation of C-fibres in guinea-pig bronchi","volume":"215","author":"Belvisi","year":"1992","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0953-6205(99)00071-0","article-title":"New treatments for asthma","volume":"11","author":"Barnes","year":"2000","journal-title":"Eur J Int Med"},{"key":"10.1016\/j.pupt.2006.03.002_bib18","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrd1524","article-title":"New drugs for asthma","volume":"3","author":"Barnes","year":"2004","journal-title":"Nat Rev Drug Disc"},{"key":"10.1016\/j.pupt.2006.03.002_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/PL00000304","article-title":"Asthma therapy in the new millennium","volume":"51","author":"Pahl","year":"2002","journal-title":"Inflammation Res"},{"key":"10.1016\/j.pupt.2006.03.002_bib20","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1183\/09031936.01.00252501","article-title":"Pharmacological treatment of asthma today","volume":"18","author":"Rabe","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2006.03.002_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1476-5381.1985.tb08827.x","article-title":"Effects of bronchoconstrictors and bronchodilators on a novel human small airway preparation","volume":"85","author":"Finney","year":"1985","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pupt.2006.03.002_bib22","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1124\/pr.56.4.2","article-title":"Mediators of chronic obstructive pulmonary disease","volume":"56","author":"Barnes","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pupt.2006.03.002_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1042\/CS20040342","article-title":"Structural changes in the airways in asthma: observations and consequences","volume":"108","author":"Bai","year":"2005","journal-title":"Clin Sci"},{"key":"10.1016\/j.pupt.2006.03.002_bib24","first-page":"85","article-title":"Inhibition by capsazepine of resiniferatoxin- and capsaicin induced contractions of guinea pig trachea","volume":"268","author":"Ellis","year":"1994","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553906000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553906000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:57:17Z","timestamp":1736398637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553906000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1094553906000356"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2006.03.002","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}